1.  Monforte AD, Testa L, Adorni F, et al. Clinical outcome and
    predictive factors of failure of highly active antiretroviral
    therapy in antiretroviral-experienced patients in advanced stages of
    HIV-1 infection. AIDS 1998; 12:1631-7.

2.  Wit FW, Van Leeuwen GJ, Jurriaans S, et al. Outcome and predictors
    of failure of highly active antiretroviral therapy: one-year
    follow-up of a cohort of human immunodeficiency type 1-infected
    persons. J Infect Dis 1999; 179:790-8.

3.  Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients
    with HIV-1 infection according to immunologic and virologic response
    after 6 months of highly active antiretroviral therapy. Ann Intern
    Med 2000; 133:401-410.

4.  Deeks SG, Hecht FM, Swanson M, et al. HIV RNA and CD4 cell count
    response to protease inhibitor therapy in an urban AIDS clinic:
    response to both initial and salvage therapy. AIDS 1999; 13:
    F35-F43.

5.  Ledergerber B, Egger M, Opravil M, et al. Clinical progression and
    virologic failure on highly active antiretroviral therapy in HIV-1
    patients: a prospective cohort study. Lancet 1999; 353: 863-68.

6.  Staszewski S, Miller V, Sabin C, et al. Virologic response to
    protease inhibitor therapy in an HIV clinic cohort. AIDS 1999; 13:
    367-73.

7.  Gulick RM, Hu XJ, Fiscus SA, et al. Randomized study of saquinavir
    with ritonavir or nelfinavir together with delavirdine, adefovir, or
    both in human immunodeficiency virus-infected adults with virologic
    failure on indinavir: AIDS Clinical Trials Group Study 359. J Infect
    Dis 2000; 182: 1375-84.

8.  Khanna N, Klimkait T, Schiffer V, et al. Salvage therapy with
    abacavir plus a non-nucleoside reverse transcriptase inhibitor and a
    protease inhibitor in heavily pre-treated HIV-1 infected patients.
    AIDS 2000; 14: 791-99.

9.  Fätkenheuer G, Hoetelmans RM, Hunn N, et al. Salvage therapy with
    regimens containing ritonavir and saquinavir in extensively
    pretreated HIV-infected patients. AIDS 1999; 13: 1485-9.

10. Piketty C, Race E, Castiel P, et al. Efficacy of a five-drug
    combination including ritonavir, saquinavir and efavirenz in
    patients who failed on a conventional triple-drug regimen:
    phenotypic resistance to protease inhibitors predicts outcome of
    therapy. AIDS 1999; 13: F71-7.

11. Hall CS, Raines CP, Barnett SH, et al. Efficacy of salvage therapy
    containing ritonavir and saquinavir after failure of single protease
    inhibitor-containing regimens. AIDS 1999; 13: 1207-12.

12. Deeks SG, Grant RM, Beatty GW, et al. Activity of a ritonavir plus
    saquinavir-containing regimen in patients with virologic evidence of
    indinavir or ritonavir failure. AIDS 1998; 12: F97-F102.

13. Shulman NS, Zolopa AR, Passaro DJ, et al. Efavirenz- and adefovir
    dipivoxil-based salvage therapy in highly treatment-experienced
    patients: clinical and genotypic predictors of virologic response.
    JAIDS 2000; 23; 221-6.

14. Gilbert P, DeGruttola V, and Hammer S. Efficient trial designs for
    studying combination antiretroviral treatments in patients with
    various resistance profiles. J Infect Dis 1998; 178: 340-8.

15. Paredes R, Puig T, Arno A, et al. High-dose saquinavir plus
    ritonavir: long-term efficacy in HIV-positive protease
    inhibitor-experienced patients and predictors of virologic response.
    JAIDS 1999; 22: 132-8.

16. Khanna N, Klimkait T, Schiffer V, et al. Salvage therapy with
    abacavir plus a non-nucleoside reverse transcriptase inhibitor and a
    protease inhibitor in heavily pre-treated HIV-1 infected patients.
    AIDS 2000; 14: 791-9.

17. Mocroft A, Lundgren JD, and Phillips AN. Response to salvage therapy
    in patients exposed to all three classes of antiretrovirals: the
    EuroSIDA study. Third International Workshop on Salvage Therapy for
    HIV Infection. Chicago, April 2000 \[4\].

18. Fessel WJ, Follansbee SE, and Young TP. Success rates of salvage
    treatment after two or more failures of HAART. Third International
    Workshop on Salvage Therapy for HIV Infection. Chicago, April 2000
    \[8\].

19. Youle M, Phillips A, Loveday C, et al. Prolonged viral suppression
    after introduction of a post HAART salvage regimen. Third
    International Workshop on Salvage Therapy for HIV Infection.
    Chicago, April 2000 \[23\].

20. Montaner J, Harrigan R, Raboud J, et al. Multi-drug rescue therapy
    in three cohorts of HIV-positive individuals. Third International
    Workshop on Salvage Therapy for HIV Infection. Chicago, April 2000
    \[24\].

21. Schooley R, Myers R, Ruane P, et al. Tenofovir disoproxil fumarate
    (TDF) for the treatment of antiretroviral experienced patients. A
    double blind, placebo-controlled study. Fortieth Interscience
    Conference on Antimicrobial Agents and Chemotherapy. Toronto,
    September 2000 \[692\].

22. Meynard JL, Vray M, Morand-Joubert L, et al. Impact of treatment
    guided by phenotypic or genotypic tests on the response to
    antiretroviral therapy (ART): a randomised trial (NARVAL, ANRS 088).
    Fortieth Interscience Conference on Antimicrobial Agents and
    Chemotherapy. Toronto, September 2000 \[698\].

23. Walsh JC, Hertogs K, and Gazzard BG. Viral drug resistance,
    adherence and pharmacokinetic indices in HIV-1 infected patients on
    successful and failing protease inhibitor (PI) based highly active
    antiretroviral therapy. Fortieth Interscience Conference on
    Antimicrobial Agents and Chemotherapy. Toronto, September 2000
    \[699\].

24. Ross LL, Liao Q, Johnson VA, et al. Impact of HIV-1 drug resistance
    mutations and phenotypic resistance profile on virologic response to
    salvage therapy in an observational cohort. Fortieth Interscience
    Conference on Antimicrobial Agents and Chemotherapy. Toronto,
    September 2000 \[1260\].

25. Arasteh K, Zwingers T, Sternfeld T, et al. Value of genotyping in
    heavily pretreated patients (the Berlin Cohort). Fortieth
    Interscience Conference on Antimicrobial Agents and Chemotherapy.
    Toronto, September 2000 \[1261\].